Cyclotron rigging completed in Guangzhou, Guangdong Province, China
Current Location:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

Blue Cross and Blue Shield of Minnesota and Minnesota Oncology announce five-year collaboration

Wisconsin cancer network first to use Accuray Radixact System with Synchrony motion and correction technology

CDR Systems introduces the PowerWEDGE radiation therapy positioning device with patient comfort in mind

New proton beam therapy centre in Berkshire to meet rising demand

ViewRay shows results of first prospective clinical trial on MR-guided radiotherapy for prostate cancer sans implanted markers

Sunnybrook Health Sciences Centre treats its first patient with Elekta Unity MR-Linac

Drug accelerates blood system's recovery after chemotherapy, radiation

Oklahoma Proton Center offering short course partial breast irradiation treatment

C-RAD and Mevion release integration for improved treatment quality in proton therapy

Spacer protects healthy organs from radiation exposure during particle therapy

Cyclotron rigging completed in Guangzhou, Guangdong Province, China

Press releases may be edited for formatting or style
Louvain-La-Neuve, Belgium, 15 July 2019 - IBA (Ion Beam Applications S.A., EURONEXT), the world's leading provider of proton therapy solutions for the treatment of cancer, today announces the arrival and rigging of the 220-ton Cyclone®230 cyclotron at the Proton International Guangzhou Center located in Guangzhou, Guangdong Province, China. This innovative cancer center led by the Guangdong Hengjian Nuclear Medical Industry Co., Ltd will be equipped with IBA's Proteus®PLUS solution, optimized for best-in-class treatment with three-gantry treatment rooms with Pencil Beam Scanning (PBS), integrated Cone Beam CT Image Guidance (CBCT) and ultra-high dose rate capability for flash irradiation research.

Mr. Han Lianhe, Chairman of Hebei United Medical Management, Mr. Wang Wei, Board of Director of Guangdong Hengjian Investment, and several other investors and government officials were also present, such as the official delegate from the Belgium Embassy with Mr Joris Salden, the Consul General of Belgium in Guangzhou and Ms Catherine Huang, commercial secretary. In total, more than 100 people participated in this exciting event well covered by local news and press. This type of event underscores the enthusiasm of people who work for IBA, a company that provides exemplary customer service and most importantly, contributes to improving people's lives.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



To date, IBA has sold 55 proton therapy centres worldwide, with five of them located in China.

Olivier Legrain, Chief Executive Officer of IBA, commented: "We are proud to deliver this important installation milestone to a facility of such quality and importance in South China. IBA's experience in proton therapy makes us ideally suited to partner to bring proton therapy to more patients across China who will benefit from this leading-edge cancer treatment. With 50 per cent of the market share and the rigging of a new center in China, IBA increases its leadership in potentially the largest radiotherapy market in the world."

Mr Han Lianhe, Chairman of Hebei United Medical Management, commented: "Today, the rigging ceremony marks a milestone in the construction of this proton therapy center. Here in Guangzhou we are creating one of the most advanced oncology therapy center in Asia, all thanks to IBA's technological leadership in proton therapy.


About IBA
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA's proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,400 people worldwide, IBA has installed systems across the world.
  Pages: 1 - 2 >>

Rad Oncology Homepage


You Must Be Logged In To Post A Comment